Literature DB >> 29526989

Twelve-year trends of increasing overweight and obesity in patients with diabetes: the Shiga Diabetes Clinical Survey.

Itsuko Miyazawa1, Aya Kadota2,3, Katsuyuki Miura2,3, Motozumi Okamoto4, Takashi Nakamura5,6, Tsuyoshi Ikai7,6, Hiroshi Maegawa1, Atsushi Ohnishi8,6.   

Abstract

The prevalence of obesity is increasing globally in patients with diabetes. This study aimed to examine 12-year trends of increasing obesity in Japanese patients with diabetes, and their clinical features. The study used results of the Shiga Diabetes Clinical Survey, which recorded medical performance in diabetic patients in 2000, 2006 and 2012. Data were analyzed from 14,205, 14,407 and 21,449 adult patients in these three years, respectively. Overweight and obesity prevalence and the clinical features of diabetes patients were examined, stratified by body mass index (BMI) and age. The prevalence of overweight (BMI 25-30 kg/m2) and obesity (BMI ≥30 kg/m2) were 27.0% and 5.1% in 2000, 28.9% and 7.3% in 2006 and 30.9% and 10.0% in 2012. Glycemic control, blood pressure and serum lipid profile improved over 12 years in all BMI categories. However, glycemic and triglyceride control were insufficient in obese patients aged <65 years (hemoglobin A1c 7.5 ± 1.4%, triglyceride 197.7 ± 178.4 mg/dL in 2012). The percentage of patients who used antihypertensive and lipid-lowering drugs increased and patients with higher BMI had increased frequency of using these drugs, both in young and old age groups. Higher BMI was significantly and positively associated with albuminuria. In summary, overweight and obesity have increased in Japanese diabetic patients, particularly for younger generations. Findings suggest that obesity may lead to poorer glycemic control, blood pressure and lipid profiles. Overweight and obesity are important modifiable risk factors for diabetes, suggesting that more active weight-control interventions are warranted.

Entities:  

Keywords:  Albuminuria; Clinical survey; Diabetes mellitus; Obesity; Overweight

Mesh:

Substances:

Year:  2018        PMID: 29526989     DOI: 10.1507/endocrj.EJ17-0415

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  6 in total

1.  Eighteen-year trends in the management of patients with diabetes in the Shiga Diabetes Clinical Survey: overall trends and differences by age group.

Authors:  Itsuko Miyazawa; Hiroshi Maegawa; Aya Kadota; Takashi Nakamura; Makoto Konishi; Shinichi Ochi; Katsuyuki Miura; Motozumi Okamoto
Journal:  Diabetol Int       Date:  2022-02-17

2.  Impact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study).

Authors:  Alper Sonmez; Volkan Yumuk; Cem Haymana; Ibrahim Demirci; Cem Barcin; Sinem Kıyıcı; Sibel Güldiken; Gonca Örük; Basak Ozgen Saydam; Süleyman Baldane; Faruk Kutlutürk; Ferit Kerim Küçükler; Oğuzhan Deyneli; Berrin Çetinarslan; Tevfik Sabuncu; Fahri Bayram; Ilhan Satman
Journal:  Obes Facts       Date:  2019-03-20       Impact factor: 4.807

3.  A phase 1 multiple-ascending dose study of tirzepatide in Japanese participants with type 2 diabetes.

Authors:  Kenichi Furihata; Hanaka Mimura; Shweta Urva; Tomonori Oura; Kenji Ohwaki; Takeshi Imaoka
Journal:  Diabetes Obes Metab       Date:  2021-11-18       Impact factor: 6.408

Review 4.  Nutrition Management in Older Adults with Diabetes: A Review on the Importance of Shifting Prevention Strategies from Metabolic Syndrome to Frailty.

Authors:  Yoshiaki Tamura; Takuya Omura; Kenji Toyoshima; Atsushi Araki
Journal:  Nutrients       Date:  2020-11-01       Impact factor: 5.717

5.  Trends in maternal characteristics and perinatal outcomes among Japanese pregnant women with type 1 and type 2 diabetes from 1982 to 2020.

Authors:  Kei Fujikawa Shingu; Masako Waguri; Mitsuyoshi Takahara; Naoto Katakami; Iichiro Shimomura
Journal:  J Diabetes Investig       Date:  2022-05-31       Impact factor: 3.681

6.  Adult-onset autoimmune diabetes identified by glutamic acid decarboxylase autoantibodies: a retrospective cohort study.

Authors:  Eri Wada; Takeshi Onoue; Tamaki Kinoshita; Ayaka Hayase; Tomoko Handa; Masaaki Ito; Mariko Furukawa; Takayuki Okuji; Tomoko Kobayashi; Shintaro Iwama; Mariko Sugiyama; Hiroshi Takagi; Daisuke Hagiwara; Hidetaka Suga; Ryoichi Banno; Motomitsu Goto; Hiroshi Arima
Journal:  Diabetologia       Date:  2021-07-15       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.